 |
| Global EPA And DHA Market Size |
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 fatty
acids known for their cardiovascular and brain health benefits. EPA and DHA
find wide applications in infant formula, dietary supplements, functional food
and beverages, pharmaceuticals, and animal feed due to their numerous health
advantages. Rising awareness about the importance of EPA and DHA in preventing
heart disease, depression, and other ailments has accelerated the demand for
products containing these fatty acids.
The global
EPA and DHA Market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period
2024-2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The growing usage of EPA and DHA in infant formula is one of the key trends
driving the market. According to studies, regular supplementation of infant
formula with omega-3 fatty acids promotes retinal and brain development in
infants. Consequently, parents are increasingly feeding their babies infant
formula fortified with DHA and EPA. Product innovations catering to this demand
are further stimulating the sales of EPA and DHA. For instance, companies are
developing new vegetarian and vegan sources of DHA and EPA for infant formula
to cater to the needs of increasing health-conscious populations.
Segment Analysis
The global EPA and DHA market is dominated by the dietary supplements segment.
The increasing consumer awareness regarding the health benefits of EPA and DHA
intake through dietary supplements is driving the growth of this segment. EPA
and DHA supplements help in boosting brain health, improving cardiovascular
health, promoting eye health, maintaining joints and reducing inflammation.
This makes dietary supplements the preferred choice for regular EPA and DHA
consumption.
Key Takeaways
Global
EPA And DHA Market Size is expected to witness high growth over the
forecast period of 2024 to 2031. The global EPA and DHA Market is estimated to
be valued at US$ 2135.1 Mn in 2024
and is expected to exhibit a CAGR of
4.5% over the forecast period 2024-2031.
Regional analysis
North America is currently the dominant regional market for EPA and DHA. The
rising prevalence of lifestyle diseases and increasing consumer awareness
regarding nutrition are encouraging higher intake of EPA and DHA supplements in
the region. The US accounts for the major share in the North American as well
as global EPA and DHA market.
Key players
Key players operating in the EPA and DHA market are KHS GmbH, Tetra Pak
International SA, Syntegon Technology GmbH, JBT Corporation, GEA Group
Aktiengesellschaft, Sidel Group, Krones AG, Ronchi Mario SPA, Coesia Group.
These players are focusing on new product launches and expansions to strengthen
their market presence. For instance, in 2022, Tetra Pak International SA
launched a new aseptic filling machine, the Tetra A3 IS line, which offers high
production capacity for drinks, dairy, and liquid food products.
Explore More Related Article On This
Topic: https://www.pressreleasebulletin.com/epa-and-dha-market-share/
Explore More Related Article: https://www.timessquarereporter.com/news/unveiling-trends-and-opportunities-in-the-dynamic-india-alcohol-market